Medirom Healthcare Technologies Inc.: Form 20-F for the period ended Dec 31, 2021
Filed with the SEC on Nov 14, 2022 and accepted by EDGAR at Nov 14, 2022, 20:47 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2021-01-01 to 2021-12-31 | JPY 5.41bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Selling, general and administrative | 12 months2021-01-01 to 2021-12-31 | JPY 1.82bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2021-01-01 to 2021-12-31 | −JPY 470.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2021-01-01 to 2021-12-31 | JPY 11.9m | us-gaap:InterestExpense |
| Income tax | 12 months2021-01-01 to 2021-12-31 | JPY 576.3m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2021-01-01 to 2021-12-31 | −JPY 990.7m | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months2021-01-01 to 2021-12-31 | −JPY 203.13 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2021-01-01 to 2021-12-31 | −JPY 203.13 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2021-01-01 to 2021-12-31 | 4,877,404 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2021-01-01 to 2021-12-31 | −JPY 557.2m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2021-01-01 to 2021-12-31 | JPY 95.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Current assets | At period end2021-12-31 | JPY 1.38bn | us-gaap:AssetsCurrent |
| Total assets | At period end2021-12-31 | JPY 5.75bn | us-gaap:Assets |
| Current liabilities | At period end2021-12-31 | JPY 3.20bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-12-31 | JPY 5.96bn | us-gaap:Liabilities |
| Long-term debt | At period end2021-12-31 | JPY 746.6m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2021-12-31 | JPY 162.3m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2021-12-31 | −JPY 208.3m | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2021-12-31 | 4,882,500 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001558370-22-017729. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.